{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:45:18Z","timestamp":1765079118343,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1992,9]]},"abstract":"<jats:p>Antinuclear antibodies with the homogeneous pattern (ANA-H) and smooth muscle antibodies with antiactin specificity (SMA-AA) are regarded as the serum markers of type-1 autoimmune chronic hepatitis. Their diagnostic relevance, however, has been questioned recently after the detection of signs of hepatitis C virus infection in autoimmune chronic hepatitis patients. To further evaluate this point, antihepatitis C virus antibodies were sought by two second generation assays (ELISA 2 and RIBA 2) in 100 Italian patients with chronic liver disease of unknown aetiology, including 46 with (autoimmune chronic hepatitis) and 54 without the above antibodies (cryptogenic). By ELISA 2, antihepatitis C virus, although significantly prevalent in cryptogenic (83%), were found also in a substantial proportion of autoimmune chronic hepatitis patients (46%) (p &lt; 0.0001), their occurrence was confirmed by RIBA 2 in almost all cases (96% and 86%, respectively). Autoimmune patients with either ANA-H or SMA-AA exhibited similar antihepatitis C virus prevalences (59% and 52%, respectively); by contrast, the eight cases positive for both the autoantibodies were consistently antihepatitis C virus negative. These findings confirm that in countries with high hepatitis C virus circulation (like Italy) an overlap between autoimmune chronic hepatitis and hepatitis C virus infection, reflected by 'true' antihepatitis C virus antibodies, does occur. The detection of ANA-H or SMA-AA, in fact, identifies chronic liver disease patients with a relatively low prevalence of antihepatitis C virus, but does not exclude hepatitis C virus infection. Positive findings for both ANA-H and SMA-AA, however, is an appropriate marker for hepatitis C virus free 'primary' autoimmune chronic hepatitis.<\/jats:p>","DOI":"10.1136\/gut.33.9.1260","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"1260-1263","source":"Crossref","is-referenced-by-count":38,"title":["Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection."],"prefix":"10.1136","volume":"33","author":[{"given":"F","family":"Cassani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Manotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Fusconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ballardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Selleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Volta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Zauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Miniero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1992,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(89)91544-4","article-title":"Classifying chronic hepatitis","volume":"ii:","author":"Sherlock, S.","year":"1989","unstructured":"Sherlock S. Classifying chronic hepatitis. Lancet 1989; ii: 1168-70.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.1840030517","article-title":"Immunological aspects of chronic active hepatitis","volume":"3","author":"Mackay, I.R.","year":"1983","unstructured":"Mackay IR. Immunological aspects of chronic active hepatitis. Hepatology 1983; 3: 724-8.","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hep.1840050309","article-title":"The immunologic diagnosis of chronic active 'autoimmune' hepatitis: distinction from systemic lupus erythematosus","volume":"5","author":"Gurian, L.E.; Rogoff, T.M.; Ware, A.J.; Jordan, R.E.; Combes, B.; Gilliam, J.N.","year":"1985","unstructured":"Gurian LE, Rogoff TM, Ware AJ, Jordan RE, Combes B, Gilliam JN. The immunologic diagnosis of chronic active 'autoimmune' hepatitis: distinction from systemic lupus erythematosus. Hepatology 1985; 5: 397-402.","journal-title":"Hepatology"},{"key":"ref_4","first-page":"588","article-title":"Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol","volume":"68","author":"Cassani, F.; Fusconi, M.; Bianchi, F.B.","year":"1987","unstructured":"Cassani F, Fusconi M, Bianchi FB, et al. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol 1987; 68: 588-95."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.38.7.801","article-title":"Immunomorphological characterization of antinuclear antibodies in chronic liver disease","volume":"38","author":"Cassani, F.; Bianchi, F.B.; Lenzi, M.; Volta, U.; Pisi, E.","year":"1985","unstructured":"Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E. Immunomorphological characterization of antinuclear antibodies in chronic liver disease.J Clin Pathol 1985; 38: 801-5.","journal-title":"J Clin Pathol"},{"key":"ref_6","first-page":"766","article-title":"An autoantibody reactive with nuclei of polymorphonuclear neutrophils: a cell differentiation marker","volume":"58","author":"Whittingham, S.; Morstyn, G.; Wilson, J.W.","year":"1981","unstructured":"Whittingham S, Morstyn G, Wilson JW, et al. An autoantibody reactive with nuclei of polymorphonuclear neutrophils: a cell differentiation marker. Blood 1981; 58: 766-71.","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo, G.; Choo, Q.L.; Alter, H.J.","year":"1989","unstructured":"Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0168-8278(91)90956-C","article-title":"Anti-HCV antibodies detected by ELISA in autoimmune and cryptogenic chronic liver disease","volume":"12","author":"Cassani, F.; Ballardini, G.; Fusconi, M.","year":"1991","unstructured":"Cassani F, Ballardini G, Fusconi M, et al. Anti-HCV antibodies detected by ELISA in autoimmune and cryptogenic chronic liver disease. J Hepatol 1991; 12: 269-70.","journal-title":"J Hepatol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(89)90485-6","article-title":"Hepatitis C virus antibodies among risk groups in Spain","volume":"ii:","author":"Esteban, J.I.; Esteban, R.; Viladomiu, L.","year":"1989","unstructured":"Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294-7.","journal-title":"Lancet"},{"key":"ref_10","article-title":"Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology","author":"Leevy, C.M.; Popper, H.; Sherlock, S.","year":"1976","unstructured":"Leevy CM, Popper H, Sherlock S. Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology. Chicago: Year Book Medical Publishers, 1976."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(90)90291-3","article-title":"Anti-actin antibodies: a new test for an old problem","volume":"130","author":"Fusconi, M.; Cassani, F.; Zauli, D.","year":"1990","unstructured":"Fusconi M, Cassani F, Zauli D, et al. Anti-actin antibodies: a new test for an old problem. J Immunol Methods 1990; 130: 1-8.","journal-title":"J Immunol Methods"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies (SMA) detected by immunofluorescence","volume":"29","author":"Bottazzo, G.F.; Florin-Christensen, A.; Fairfax, A.; Swana, G.; Doniach, D.; Groeschel-Stewart, U.","year":"1976","unstructured":"Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies (SMA) detected by immunofluorescence. J Clin Pathol 1976; 29: 403-10.","journal-title":"J Clin Pathol"},{"key":"ref_13","first-page":"527","article-title":"Segregation of autoantibody to cytoskeleton filaments, actin and intermediate filaments, with two types of chronic active hepatitis. Clin Exp Immunol","volume":"48","author":"Pedersen, J.S.; Toh, B.H.; Mackay, I.R.","year":"1982","unstructured":"Pedersen JS, Toh BH, Mackay IR, et al. Segregation of autoantibody to cytoskeleton filaments, actin and intermediate filaments, with two types of chronic active hepatitis. Clin Exp Immunol 1982; 48: 527-32."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0140-6736(90)90070-L","article-title":"Type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"335","author":"Lenzi, M.; Ballardini, G.; Fusconi, M.","year":"1990","unstructured":"Lenzi M, Ballardini G, Fusconi M, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258-9.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jmv.1890340405","article-title":"Hepatitis C viraemia in adults with type 2 autoimmune hepatitis","volume":"34","author":"Garson, J.A.; Lenzi, M.; Ring, C.","year":"1991","unstructured":"Garson JA, Lenzi M, Ring C, et al. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 1991; 34: 223-6.","journal-title":"J Med Virol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0168-8278(91)90864-8","article-title":"Is autoimmune chronic active hepatitis a HCV-related disease?","volume":"13","author":"Magrin, S.; Craxi, A.; Fiorentino, G.","year":"1991","unstructured":"Magrin S, Craxi A, Fiorentino G, et al. Is autoimmune chronic active hepatitis a HCV-related disease? J Hepatol 1991; 13: 56-60.","journal-title":"J Hepatol"},{"key":"ref_17","first-page":"797","article-title":"Antibodies to hepatitis C virus in Italian blood donors","volume":"ii:","author":"Sirchia, G.; Bellobuono, A.; Giovanetti, A.; Marconi, M.","year":"1989","unstructured":"Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet 1989; ii: 797.","journal-title":"Lancet"},{"key":"ref_18","first-page":"39","article-title":"Absence of autoimmune serological reactions in chronic non-A, non-B viral hepatitis. Clin Exp Immunol","volume":"61","author":"Mackay, I.R.; Frazer, I.H.; Toh, B.H.; Pedersen, J.S.; Alter, H.J.","year":"1985","unstructured":"Mackay IR, Frazer IH, Toh BH, Pedersen JS, Alter HJ. Absence of autoimmune serological reactions in chronic non-A, non-B viral hepatitis. Clin Exp Immunol 1985; 61: 39-43."},{"key":"ref_19","first-page":"171","article-title":"Markers of 'viral' autoimmunity in chronic non-A, non-B post-transfusion hepatitis","volume":"20","author":"Cassani, F.; Tremolada, F.; Baffoni, L.","year":"1988","unstructured":"Cassani F, Tremolada F, Baffoni L, et al. Markers of 'viral' autoimmunity in chronic non-A, non-B post-transfusion hepatitis. ItalJ7 Gastroenterol 1988; 20: 171-4."},{"key":"ref_20","first-page":"285","article-title":"Genetic determinants of autoimmune chronic active hepatitis","volume":"3","author":"Mackay, I.R.; Whittingham, S.; Mathews, J.D.","year":"1980","unstructured":"Mackay IR, Whittingham S, Mathews JD, et al. Genetic determinants of autoimmune chronic active hepatitis. Springer Semin Immunopathol 1980; 3: 285-96."},{"key":"ref_21","first-page":"332","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta agent. Clin Exp Immunol","volume":"54","author":"Crivelli 0, Lavarini C, Chaberge E","year":"1983","unstructured":"Crivelli 0, Lavarini C, Chaberge E, et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta agent. Clin Exp Immunol 1983; 54: 332-8."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.1840040601","article-title":"Close association between basal cell layer antibodies and hepatitis B virus-associated chronic delta infection","volume":"4","author":"Zauli, D.; Fusconi, M.; Crespi, C.; Bianchi, F.B.; Crazi, A.; Pisi, E.","year":"1984","unstructured":"Zauli D, Fusconi M, Crespi C, Bianchi FB, Crazi A, Pisi E. Close association between basal cell layer antibodies and hepatitis B virus-associated chronic delta infection. Hepatology 1984; 4: 1103-6.","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0140-6736(91)90418-O","article-title":"Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity","volume":"338","author":"Lenzi, M.; Johnson, P.J.; McFarlane, I.G.","year":"1991","unstructured":"Lenzi M, Johnson PJ, McFarlane IG, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277-80.","journal-title":"Lancet"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.33.9.1260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:49:36Z","timestamp":1757270976000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.33.9.1260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[1992,9,1]]},"published-print":{"date-parts":[[1992,9]]}},"alternative-id":["10.1136\/gut.33.9.1260"],"URL":"https:\/\/doi.org\/10.1136\/gut.33.9.1260","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1992,9]]}}}